Archive for September 22, 2020
Novartis, Siemens to develop blood tests for multiple sclerosis
Siemens Healthineers has inked what it describes as a “master collaboration agreement” with Novartis to help provide diagnostic tests linked to therapies across the drugmaker’s pipeline. To start, the companies will design and develop a biomarker test aimed at neuroscience programs, and multiple sclerosis specifically—a treatment area that they expect to expand into a $23.5…
Read MoreFDA poised to announce tougher standards for a covid-19 vaccine
The Food and Drug Administration is expected to spell out a tough new standard for an emergency authorization of a coronavirus vaccine as soon as this week that will make it exceedingly difficult for any vaccine to be cleared before Election Day. The agency is issuing the guidance to boost transparency and public trust as…
Read MoreBetter testing can fight more than the pandemic
New coronavirus diagnostics could eventually enable near-constant testing — and herald a future where even common infections no longer go undiagnosed. Why it matters: Rapid testing could be especially important during the winter, when it will become vital to quickly distinguish between an ordinary cold or flu and a new disease like COVID-19. What’s happening: New testing…
Read MoreSEC Adopts Rule Amendments to Provide Investors Using Proxy Voting Advice More Transparent, Accurate and Complete Information
SEC Issues Supplemental Guidance Concerning Proxy Voting Responsibilities of Investment Advisers Washington D.C., July 22, 2020 — The Securities and Exchange Commission today voted to adopt amendments to its rules governing proxy solicitations designed to ensure that clients of proxy voting advice businesses have reasonable and timely access to more transparent, accurate and complete information…
Read MoreInvesting in racial diversity: a call to action to the venture capital community
To the Editor — The murder of George Floyd has yet again shone a spotlight on racial injustice and police brutality in the United States, his death joining the collective history of violence and inequality faced by racial minorities in this country and beyond. Floyd’s killing by police also brought back the teachings of my father,…
Read MoreConfusion spreads over system to determine priority access to Covid-19 vaccines
As manufacturers around the world race to develop Covid-19 vaccines, a parallel effort has begun to figure out who in the United States should get them first — and how those doses should be distributed. But already the effort is being complicated by tensions over who gets to make those critical decisions, with some groups…
Read MoreU.S. to pay Pfizer, BioNTech $1.95 billion for COVID-19 vaccine
The U.S. government will pay nearly $2 billion to buy enough of a COVID-19 vaccine being developed by Pfizer Inc (PFE.N) and German biotech BioNTech SE (22UAy.F) to innoculate 50 million people if it proves to be safe and effective, the companies said on Wednesday. The contract for 100 million doses of the vaccine amounts…
Read MoreSingh Awarded $2.3 Million National Cancer Institute Grant for Diffuse Large B Cell Lymphoma Research
Grant to focus on developing engineered experimental therapeutics technologies to understand the mechanism of resistance in diffuse large B cell lymphoma (DLBCL) and enable the translation of a new therapeutic to treat cancer patients better. Ankur Singh, an Associate Professor of George W. Woodruff School of Mechanical Engineering at Georgia Institute of Technology and Wallace…
Read MoreNew EPA Aircraft Emission Standard ‘Too Weak’ To Encourage New Aircraft And Engine Technologies, ICCT Finds
The U.S. Environmental Protection Agency’s proposed new emissions standards for aircraft fall short of expectations and is “too weak to accelerate investment in more fuel-efficient aircraft and engines,” according to the International Council on Clean Transportation. The environmental research organization, which specializes in tracking the environmental performance of the aviation sector, warns that the proposed EPA standard…
Read MoreNew plasma treatment under development in Georgia
As a COVID-19 survivor, Kevin Weinrich could be a key to helping others fight the disease by simply donating his blood. The idea is the antibodies in Weinrich’s plasma can help a sick patient fend off the infection. The 58-year-old computer programmer has donated his plasma, the antibody-rich liquid portion of his blood, four times over…
Read More